Last update :
29/10/2024
Radiocontrast agent   Iodixanol  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Visipaque Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Denmark, Egypt, Finland, France, Germany, Greece, Hungary, Iceland, Iran, Ireland, Italy, Luxembourg, Malaysia, New Zealand, Norway, Peru, Romania, Saudi Arabia, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United States of America, Venezuela
Compatibility   injection   Compatibility : Iodixanol              
This screen indicates the compatibilities or incompatibilities with, in this case, the type of incompatibility (precipitation, color change, modification of an emulsion, etc.). The compatibilities shown here are mostly physical only, with the chemical stability of each molecule rarely being assessed. The evaluation of these mixtures was studied to consider the possibility of Y-site administration to the patient. These data cannot be used for making mixtures in advance in bags or syringes. This type of information is available in the screen "Stability in mixture ».
Compound Solvent References
Compatible
injection Iodixanol 550 mg I/ml
injection Fenoldopam mesylate 80 µg/ml
Sodium chloride 0,9% 1803
Immediate precipitation Incompatible
injection Iodixanol 270 & 320 mg I/ml
injection Trisodium citrate 467 mg/ml
None 3486

  Mentions Légales